Efficacy of baricitinib for the treatment of systemic lupus erythematosus patients: A meta ‐analysis of randomized controlled trials

ConclusionIn treating SLE patients, administrating a higher dose of baricitinib (4  mg) may be effective. However, additional RCTs in different populations with larger sample sizes are required to validate our findings.

Source: International Journal of Rheumatic Diseases - November 11, 2023 Category: Rheumatology Authors: Aditya K. Panda, Shovit Ranjan, Jayanta K. Sahu Tags: ORIGINAL ARTICLE Source Type: research